The Research and Development Team at T-knife is responsible for driving innovation in tumor-specific T cell receptor (TCR) therapies. This multidisciplinary team of scientists and research professionals collaborates to discover, develop, and optimize novel TCRs, ensuring the efficacy and safety of therapies in pre-clinical stages. They utilize cutting-edge techniques and data analysis to advance the company’s therapeutic pipeline, ultimately aiming to improve treatment outcomes in cancer patients.
View all